Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing TNF-alpha levels
A Standard patent application filed on 24 July 1997 credited to Muller, George W.
;
Chen, Roger Shen-Chu
;
Stirling, David I.
Details
Application number :
38998
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing TNF-alpha levels
Inventor :
Muller, George W.
;
Chen, Roger Shen-Chu
;
Stirling, David I.
Agent name :
Cullens Patent and Trade Mark Attorneys
Address for service :
GPO Box 1074 BRISBANE QLD 4001
Filing date :
24 July 1997
Associated companies :
Applicant name :
Celgene Corporation
Applicant address :
86 Morris Avenue Summit NJ 07901 United States Of America